載入...
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
Direct oral anticoagulants (DOACs) were developed to compensate for the demerits of warfarin. In Japan, three factor Xa inhibitors are used for the treatment of venous thromboembolism (VTE): edoxaban, rivaroxaban, and apixaban. Despite problems, such as the inability to monitor their effect and the...
Na minha lista:
| 發表在: | J Atheroscler Thromb |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Japan Atherosclerosis Society
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5453680/ https://ncbi.nlm.nih.gov/pubmed/28392512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17005 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|